These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1331023)

  • 1. The adrenocorticotrophic hormone (4-9) analog ORG 2766 benefits autistic children: report on a second controlled clinical trial.
    Buitelaar JK; van Engeland H; de Kogel K; de Vries H; van Hooff J; van Ree J
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1149-56. PubMed ID: 1331023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior.
    Buitelaar JK; van Engeland H; de Kogel KH; de Vries H; van Hooff JA; van Ree JM
    Biol Psychiatry; 1992 Jun; 31(11):1119-29. PubMed ID: 1326339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4-9), in 14 outpatient autistic children.
    Buitelaar JK; van Engeland H; van Ree JM; de Wied D
    J Autism Dev Disord; 1990 Dec; 20(4):467-78. PubMed ID: 2177746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficits in social behavior in autism and their modification by a synthetic adrenocorticotrophic hormone (4-9) analog.
    Buitelaar JK; van Engeland H; de Kogel CH; de Vries H; van Hooff JA; van Ree JM
    Experientia; 1992 Apr; 48(4):391-4. PubMed ID: 1316288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism.
    Buitelaar JK; Dekker ME; van Ree JM; van Engeland H
    Eur Neuropsychopharmacol; 1996 Mar; 6(1):13-9. PubMed ID: 8866933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled acute dosage naltrexone study in young autistic children.
    Willemsen-Swinkels SH; Buitelaar JK; Weijnen FG; van Engeland H
    Psychiatry Res; 1995 Oct; 58(3):203-15. PubMed ID: 8570776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MSH/ACTH analog ORG 2766 in anxiety disorders.
    Den Boer JA; Westenberg HG; De Vries H
    Peptides; 1992; 13(1):109-12. PubMed ID: 1320259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ORG-2766 on brain event-related potentials of autistic children.
    Verbaten MN; Kemner C; Buitelaar JK; van Ree JM; van Beijsterveld CE; van Engeland H
    Psychiatry Res; 1996 Jun; 63(1):33-45. PubMed ID: 8832772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, open-label trial of galantamine in autistic disorder.
    Nicolson R; Craven-Thuss B; Smith J
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):621-9. PubMed ID: 17069550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
    Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
    Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
    Marcus RN; Owen R; Kamen L; Manos G; McQuade RD; Carson WH; Aman MG
    J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1110-1119. PubMed ID: 19797985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog.
    Soininen H; Koskinen T; Helkala EL; Pigache R; Riekkinen PJ
    Neurology; 1985 Sep; 35(9):1348-51. PubMed ID: 2991817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ACTH(4-9) analog ORG 2766 and recovery after brain damage in animal models--a review.
    van Rijzingen IM; Gispen WH; Spruijt BM
    Behav Brain Res; 1996 Jan; 74(1-2):1-15. PubMed ID: 8851911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study.
    den Boer JA; Westenberg HG; Mastenbroek B; van Ree JM
    Psychopharmacol Bull; 1989; 25(2):204-8. PubMed ID: 2557650
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study of D-cycloserine in subjects with autistic disorder.
    Posey DJ; Kem DL; Swiezy NB; Sweeten TL; Wiegand RE; McDougle CJ
    Am J Psychiatry; 2004 Nov; 161(11):2115-7. PubMed ID: 15514414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL
    Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.
    Bouvard MP; Leboyer M; Launay JM; Recasens C; Plumet MH; Waller-Perotte D; Tabuteau F; Bondoux D; Dugas M; Lensing P
    Psychiatry Res; 1995 Oct; 58(3):191-201. PubMed ID: 8570775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial.
    van Gerven JM; Hovestadt A; Moll JW; Rodenburg CJ; Splinter TA; van Oosterom AT; Keizer L; Drogendijk TE; Groenhout CM; Vecht CJ
    J Neurol; 1994 Jun; 241(7):432-5. PubMed ID: 7931444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
    King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.